Science & Technology

Validation of a new HPV DNA test for cervical and self-collected vaginal samples in the multicentric prospective TRACE study in Hungary

The clinical performance of the CONFIDENCE HPVTM test (NEUMANN Diagnostics Ltd.) as a first-line primary cervical cancer screening test from cervical samples collected in ThinPrep® (Hologic, Inc.) and from self-collected vaginal samples taken with the Qvintip® device (Aprovix AB) was assessed in the multicentric prospective TRACE (Triage and Risk Assessment of Cervical Precancer by Epigenetic Biomarker) trial in Hungary. Further subject of our analysis was the HPV viral load measured in the cervical samples with different clinical endpoints.

   Download Document